Literature DB >> 16254325

Inhibition of polyprotein processing and RNA replication of human rhinovirus by pyrrolidine dithiocarbamate involves metal ions.

B M Krenn1, B Holzer, E Gaudernak, A Triendl, F J van Kuppeveld, J Seipelt.   

Abstract

Pyrrolidine dithiocarbamate (PDTC) is an antiviral compound that was shown to inhibit the replication of human rhinoviruses (HRVs), poliovirus, and influenza virus. To elucidate the mechanism of PDTC, the effects on the individual steps of the infection cycle of HRV were investigated. PDTC did not interfere with receptor binding or internalization by receptor mediated endocytosis of HRV2 particles into HeLa cells. But we demonstrate that the processing of the viral polyprotein was prevented by PDTC treatment in HeLa cells infected with HRV2. Furthermore, PDTC inhibited the replication of the viral RNA, even when added four hours post infection. As PDTC is described as a metal ion binding agent, we investigated the effect of other metal chelators on the multiplication of HRV2. We show that EDTA, omicron-phenanthroline, and bathocuproine disulfonic acid do not exhibit any antiviral properties. Surprisingly, these substances, coadministered with PDTC, abolished the antiviral effect of PDTC, suggesting that metal ions play a pivotal role in the inhibition of virus multiplication. These results suggest that PDTC inhibits the activity of the viral proteases in a metal ion dependent way.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16254325      PMCID: PMC1280194          DOI: 10.1128/JVI.79.22.13892-13899.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  Genetic clustering of all 102 human rhinovirus prototype strains: serotype 87 is close to human enterovirus 70.

Authors:  Carita Savolainen; Soile Blomqvist; Mick N Mulders; Tapani Hovi
Journal:  J Gen Virol       Date:  2002-02       Impact factor: 3.891

2.  Novel biphasic effect of pyrrolidine dithiocarbamate on neuronal cell viability is mediated by the differential regulation of intracellular zinc and copper ion levels, NF-kappaB, and MAP kinases.

Authors:  K C Chung; J H Park; C H Kim; H W Lee; N Sato; Y Uchiyama; Y S Ahn
Journal:  J Neurosci Res       Date:  2000-01-01       Impact factor: 4.164

Review 3.  Treatment of picornavirus infections.

Authors:  Harley A Rotbart
Journal:  Antiviral Res       Date:  2002-02       Impact factor: 5.970

4.  Effect of treatment with zinc gluconate or zinc acetate on experimental and natural colds.

Authors:  R B Turner; W E Cetnarowski
Journal:  Clin Infect Dis       Date:  2000-11-06       Impact factor: 9.079

5.  Antiviral effects of pyrrolidine dithiocarbamate on human rhinoviruses.

Authors:  Elisabeth Gaudernak; Joachim Seipelt; Andrea Triendl; Andreas Grassauer; Ernst Kuechler
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

6.  Pleconaril: a novel antipicornaviral drug.

Authors:  J R Romero
Journal:  Expert Opin Investig Drugs       Date:  2001-02       Impact factor: 6.206

Review 7.  Recent advances in the treatment of rhinovirus infections.

Authors:  M A McKinlay
Journal:  Curr Opin Pharmacol       Date:  2001-10       Impact factor: 5.547

8.  cDNA cloning reveals that the major group rhinovirus receptor on HeLa cells is intercellular adhesion molecule 1.

Authors:  J E Tomassini; D Graham; C M DeWitt; D W Lineberger; J A Rodkey; R J Colonno
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

9.  Biochemical characterization of rhinovirus RNA-dependent RNA polymerase.

Authors:  Magdeleine Hung; Craig S Gibbs; Manuel Tsiang
Journal:  Antiviral Res       Date:  2002-11       Impact factor: 5.970

Review 10.  The treatment of rhinovirus infections: progress and potential.

Authors:  R B Turner
Journal:  Antiviral Res       Date:  2001-01       Impact factor: 5.970

View more
  11 in total

1.  Therapy of experimental influenza virus infection with pyrrolidine dithiocarbamate.

Authors:  Nadine Wiesener; Christin Zimmer; Nadine Jarasch-Althof; Peter Wutzler; Andreas Henke
Journal:  Med Microbiol Immunol       Date:  2010-12-21       Impact factor: 3.402

2.  Pyrrolidine dithiocarbamate inhibits herpes simplex virus 1 and 2 replication, and its activity may be mediated through dysregulation of the ubiquitin-proteasome system.

Authors:  Min Qiu; Yu Chen; Lin Cheng; Ying Chu; Hong-Yong Song; Zhi-Wei Wu
Journal:  J Virol       Date:  2013-06-05       Impact factor: 5.103

3.  Peripheral nerve protein expression and carbonyl content in N,N-diethlydithiocarbamate myelinopathy.

Authors:  Olga M Viquez; Holly L Valentine; David B Friedman; Sandra J Olson; William M Valentine
Journal:  Chem Res Toxicol       Date:  2007-02-27       Impact factor: 3.739

4.  Copper accumulation and lipid oxidation precede inflammation and myelin lesions in N,N-diethyldithiocarbamate peripheral myelinopathy.

Authors:  Olga M Viquez; Holly L Valentine; Kalyani Amarnath; Dejan Milatovic; William M Valentine
Journal:  Toxicol Appl Pharmacol       Date:  2008-01-26       Impact factor: 4.219

5.  Antiviral activity of the zinc ionophores pyrithione and hinokitiol against picornavirus infections.

Authors:  B M Krenn; E Gaudernak; B Holzer; K Lanke; F J M Van Kuppeveld; J Seipelt
Journal:  J Virol       Date:  2008-10-15       Impact factor: 5.103

6.  Quercetin inhibits rhinovirus replication in vitro and in vivo.

Authors:  Shyamala Ganesan; Andrea N Faris; Adam T Comstock; Qiong Wang; Suparna Nanua; Marc B Hershenson; Uma S Sajjan
Journal:  Antiviral Res       Date:  2012-03-23       Impact factor: 5.970

7.  Respiratory Viral Infections and Subversion of Cellular Antioxidant Defenses.

Authors:  Narayana Komaravelli; Antonella Casola
Journal:  J Pharmacogenomics Pharmacoproteomics       Date:  2014-09-30

Review 8.  Antioxidant therapy as a potential approach to severe influenza-associated complications.

Authors:  Noboru Uchide; Hiroo Toyoda
Journal:  Molecules       Date:  2011-02-28       Impact factor: 4.411

Review 9.  Redox Biology of Respiratory Viral Infections.

Authors:  Olga A Khomich; Sergey N Kochetkov; Birke Bartosch; Alexander V Ivanov
Journal:  Viruses       Date:  2018-07-26       Impact factor: 5.048

Review 10.  The human rhinovirus: human-pathological impact, mechanisms of antirhinoviral agents, and strategies for their discovery.

Authors:  Judith M Rollinger; Michaela Schmidtke
Journal:  Med Res Rev       Date:  2011-01       Impact factor: 12.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.